Skip to main content
Clinical Trials/IRCT20230808059082N1
IRCT20230808059082N1
Not yet recruiting
Phase 3

Evaluation of the Effect of Topical Lotion of Myrtus communts and Phyllanthus emblica on the Androgenic Alopecia in Women: A Clinical Trial Study

Tehran University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Androgenic alopecia.
Sponsor
Tehran University of Medical Sciences
Enrollment
120
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Females in the pre\-menopausal period complaining of hair loss
  • Patient consent to participate and fill out the informed consent form.

Exclusion Criteria

  • History of allergic response/hypersensitivity to any ingredients and pharmaceutical products.
  • History of thyroid disorder, diabetes mellitus, polycystic ovary syndrome
  • Subjects under medical treatment for hair problems, consuming drugs (such as minoxidil, finasteride, platelet rich plasma or Biotin) and laser therapy in the 2 months prior to the study
  • Subjects under medical treatment for hair problems with 5 a\-reductase inhibitors.
  • Subjects under medical treatment with antiandrogenic agents (such as spironolactone, cimetidine and cyproterone acetate) in the 2 months prior to the study
  • Subjects consuming systemic corticosteroid therapy for more than 14 days in the 2 months prior to the study
  • Any active scalp disease in the 6 months prior to the study
  • Any history of cancer or autoimmune diseases
  • History of hair transplant
  • Pregnancy or Brest \- feeding

Outcomes

Primary Outcomes

Not specified

Similar Trials